Moderate riskFDA DrugClass II

Annora lacosamide tablets recalled for possible selexipag mix-up

Some bottles of Lacosamide 100mg tablets may contain Selexipag 1000 mcg tablets instead. This mix-up happened during manufacturing and could cause patients to take the wrong medication. The recall affects specific lots distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your bottle against lots A253999 or A254000 (expiration 09/30/2027).
  2. Do not take tablets from affected bottles.
  3. Contact your pharmacist or doctor to verify your medication and get a replacement if needed.
  4. Return the bottle to the pharmacy.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
31,392 60-count bottles
Illnesses reported
None reported
Manufactured in
Sy. No.261, Plot No. 13 And 14, Annaram Village, Gummadidal Mandal, Jinnaram Mandal, Sangareddy District, Medak, Hyderabad, N/A, India
Classification
Class II
Recall number
D-0626-2026

In the FDA's words

Description
Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60. Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg. Lot: A253999, A254000, Expires: 09/30/2027. Distribution: Nationwide in the USA Affected quantity: 31,392 60-count bottles
Hazard
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.

Related topics

Label mix upDrugsSold nationwideMore from FDA Drug